Global Gastro Esophageal Reflux Disease Drug and Devices Competitive Landscape Professional Research Report 2025
Description
Research Summary
Gastroesophageal Reflux Disease (GERD) drugs and devices refer to pharmaceuticals and medical devices designed to manage and treat the symptoms and complications of GERD, a chronic condition where stomach acid frequently flows back into the esophagus, causing irritation and inflammation. GERD drugs commonly include proton pump inhibitors (PPIs) and H2 blockers, which reduce the production of stomach acid to alleviate symptoms like heartburn and regurgitation. Antacids may also be used for short-term relief. GERD devices can include antireflux barriers or surgical interventions aimed at preventing the backflow of stomach acid into the esophagus. These may include devices like the LINX Reflux Management System, a magnetic sphincter augmentation device. The development and use of drugs and devices for GERD aim to improve the quality of life for individuals suffering from this condition by managing symptoms and preventing complications such as esophageal damage and Barrett＇s esophagus.
According to DIResearch's in-depth investigation and research, the global Gastro Esophageal Reflux Disease Drug and Devices market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Gastro Esophageal Reflux Disease Drug and Devices include Endogastric Solutions, Medigus, Medtronic, Johnson & Johnson, Carbon Medical technologies etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gastro Esophageal Reflux Disease Drug and Devices. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gastro Esophageal Reflux Disease Drug and Devices market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gastro Esophageal Reflux Disease Drug and Devices market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gastro Esophageal Reflux Disease Drug and Devices industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gastro Esophageal Reflux Disease Drug and Devices Include:
Endogastric Solutions
Medigus
Medtronic
Johnson & Johnson
Carbon Medical technologies
Gastro Esophageal Reflux Disease Drug and Devices Product Segment Include:
Drugs
Devices
Gastro Esophageal Reflux Disease Drug and Devices Product Application Include:
Drugs Treatment
Surgical Treatment
Minimally Invasive Treatment
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Gastro Esophageal Reflux Disease Drug and Devices Industry PESTEL Analysis
Chapter 3: Global Gastro Esophageal Reflux Disease Drug and Devices Industry Porter’s Five Forces Analysis
Chapter 4: Global Gastro Esophageal Reflux Disease Drug and Devices Major Regional Market Size and Forecast Analysis
Chapter 5: Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Gastroesophageal Reflux Disease (GERD) drugs and devices refer to pharmaceuticals and medical devices designed to manage and treat the symptoms and complications of GERD, a chronic condition where stomach acid frequently flows back into the esophagus, causing irritation and inflammation. GERD drugs commonly include proton pump inhibitors (PPIs) and H2 blockers, which reduce the production of stomach acid to alleviate symptoms like heartburn and regurgitation. Antacids may also be used for short-term relief. GERD devices can include antireflux barriers or surgical interventions aimed at preventing the backflow of stomach acid into the esophagus. These may include devices like the LINX Reflux Management System, a magnetic sphincter augmentation device. The development and use of drugs and devices for GERD aim to improve the quality of life for individuals suffering from this condition by managing symptoms and preventing complications such as esophageal damage and Barrett＇s esophagus.
According to DIResearch's in-depth investigation and research, the global Gastro Esophageal Reflux Disease Drug and Devices market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Gastro Esophageal Reflux Disease Drug and Devices include Endogastric Solutions, Medigus, Medtronic, Johnson & Johnson, Carbon Medical technologies etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gastro Esophageal Reflux Disease Drug and Devices. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gastro Esophageal Reflux Disease Drug and Devices market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gastro Esophageal Reflux Disease Drug and Devices market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gastro Esophageal Reflux Disease Drug and Devices industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gastro Esophageal Reflux Disease Drug and Devices Include:
Endogastric Solutions
Medigus
Medtronic
Johnson & Johnson
Carbon Medical technologies
Gastro Esophageal Reflux Disease Drug and Devices Product Segment Include:
Drugs
Devices
Gastro Esophageal Reflux Disease Drug and Devices Product Application Include:
Drugs Treatment
Surgical Treatment
Minimally Invasive Treatment
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Gastro Esophageal Reflux Disease Drug and Devices Industry PESTEL Analysis
Chapter 3: Global Gastro Esophageal Reflux Disease Drug and Devices Industry Porter’s Five Forces Analysis
Chapter 4: Global Gastro Esophageal Reflux Disease Drug and Devices Major Regional Market Size and Forecast Analysis
Chapter 5: Global Gastro Esophageal Reflux Disease Drug and Devices Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Gastro Esophageal Reflux Disease Drug and Devices Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Gastro Esophageal Reflux Disease Drug and Devices Market Overview
- 1.1 Product Definition and Statistica Sclope
- 1.2 Gastro Esophageal Reflux Disease Drug and Devices Product by Type
- 1.2.1 Drugs
- 1.2.2 Devices
- 1.3 Gastro Esophageal Reflux Disease Drug and Devices Product by Application
- 1.3.1 Drugs Treatment
- 1.3.2 Surgical Treatment
- 1.3.3 Minimally Invasive Treatment
- 1.4 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size Analysis (2020-2032)
- 1.5 Gastro Esophageal Reflux Disease Drug and Devices Market Development Status and Trends
- 1.5.1 Gastro Esophageal Reflux Disease Drug and Devices Industry Development Status Analysis
- 1.5.2 Gastro Esophageal Reflux Disease Drug and Devices Industry Development Trends Analysis
- 2 Gastro Esophageal Reflux Disease Drug and Devices Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Gastro Esophageal Reflux Disease Drug and Devices Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Gastro Esophageal Reflux Disease Drug and Devices Market Analysis by Regions
- 4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share Forecast by Region (2026-2032)
- 5 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size by Type and Application
- 5.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size by Type (2020-2032)
- 5.2 Global Gastro Esophageal Reflux Disease Drug and Devices Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Type
- 6.4 North America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Application
- 6.5 North America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Size by Type
- 7.4 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Size by Application
- 7.5 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Gastro Esophageal Reflux Disease Drug and Devices Market Size by Type
- 8.4 China Gastro Esophageal Reflux Disease Drug and Devices Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Size by Type
- 9.4 APAC (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Size by Application
- 9.5 APAC (excl. China) Gastro Esophageal Reflux Disease Drug and Devices Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Type
- 10.4 Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Application
- 10.5 Latin America Gastro Esophageal Reflux Disease Drug and Devices Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Market Size by Type
- 11.4 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Market Size by Application
- 11.5 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Gastro Esophageal Reflux Disease Drug and Devices Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Gastro Esophageal Reflux Disease Drug and Devices Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Endogastric Solutions
- 13.1.1 Endogastric Solutions Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
- 13.1.3 Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Medigus
- 13.2.1 Medigus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Medigus Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
- 13.2.3 Medigus Gastro Esophageal Reflux Disease Drug and Devices Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Medtronic
- 13.3.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Medtronic Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
- 13.3.3 Medtronic Gastro Esophageal Reflux Disease Drug and Devices Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Johnson & Johnson
- 13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
- 13.4.3 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Carbon Medical technologies
- 13.5.1 Carbon Medical technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Product Portfolio
- 13.5.3 Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Gastro Esophageal Reflux Disease Drug and Devices Industry Chain Analysis
- 14.2 Gastro Esophageal Reflux Disease Drug and Devices Industry Raw Material and Suppliers Analysis
- 14.2.1 Gastro Esophageal Reflux Disease Drug and Devices Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Gastro Esophageal Reflux Disease Drug and Devices Typical Downstream Customers
- 14.4 Gastro Esophageal Reflux Disease Drug and Devices Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
